CDH1 and prostate carcinoma: In agreement with what was found in the in vitro studies, protein levels of mesenchymal markers N-Cadherin and Vimentin were higher in PC3 miR-214KO tumors versus WT tumors, whereas protein levels of E-Cadherin were lower, which was consistent with increased EMT in PC3 prostate cancer cells.